Provided by Tiger Trade Technology Pte. Ltd.

Vivos Therapeutics

0.2970
+0.01796.41%
Post-market: 0.29940.0024+0.81%19:17 EDT
Volume:122.79K
Turnover:35.45K
Market Cap:5.98M
PE:-0.16
High:0.2996
Open:0.2880
Low:0.2802
Close:0.2791
52wk High:5.12
52wk Low:0.2604
Shares:20.12M
Float Shares:17.66M
Volume Ratio:0.18
T/O Rate:0.70%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8267
EPS(LYR):-2.0700
ROE:-8585.26%
ROA:-56.19%
PB:-1.21
PE(LYR):-0.14

Loading ...

Company Profile

Company Name:
Vivos Therapeutics
Exchange:
NASDAQ
Establishment Date:
2016
Employees:
270
Office Location:
7921 Southpark Plaza,Suite 210,Littleton,Colorado,United States
Zip Code:
80120
Fax:
- -
Introduction:
Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was founded in 2016 and is based in Littleton, Colorado.

Directors

Name
Position
R. Kirk Huntsman
Chairman of the Board and Chief Executive Officer and Co-founder and Director
Anja Krammer
Director
Gregg C.E. Johnson
Director
Leonard J. Sokolow
Director
Mark F. Lindsay
Director
Matthew Thompson
Director
Ralph E. Green
Director

Shareholders

Name
Position
R. Kirk Huntsman
Chairman of the Board and Chief Executive Officer and Co-founder and Director
Bradford Amman
Chief Financial Officer